VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 183 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $100,751 | -34.4% | 23,322 | 0.0% | 0.00% | – |
| Q2 2023 | $153,692 | +3.4% | 23,322 | +6.5% | 0.00% | – |
| Q1 2023 | $148,687 | -8.1% | 21,898 | 0.0% | 0.00% | – |
| Q4 2022 | $161,826 | -25.3% | 21,898 | -0.1% | 0.00% | – |
| Q3 2022 | $216,619 | -11.6% | 21,925 | -2.5% | 0.00% | – |
| Q2 2022 | $245,065 | -5.7% | 22,483 | -2.2% | 0.00% | – |
| Q1 2022 | $259,960 | -42.0% | 22,985 | -19.6% | 0.00% | – |
| Q4 2021 | $448,000 | -8.8% | 28,576 | -0.3% | 0.00% | – |
| Q3 2021 | $491,000 | -27.5% | 28,658 | -8.9% | 0.00% | -100.0% |
| Q2 2021 | $677,000 | +45.6% | 31,460 | +1.7% | 0.00% | – |
| Q1 2021 | $465,000 | +6.7% | 30,933 | -6.7% | 0.00% | – |
| Q4 2020 | $436,000 | +39.7% | 33,171 | +2.8% | 0.00% | – |
| Q3 2020 | $312,000 | -13.8% | 32,281 | 0.0% | 0.00% | – |
| Q2 2020 | $362,000 | +3.1% | 32,281 | -4.7% | 0.00% | – |
| Q1 2020 | $351,000 | -32.4% | 33,863 | +7.1% | 0.00% | -100.0% |
| Q4 2019 | $519,000 | +16.6% | 31,605 | -3.3% | 0.00% | – |
| Q3 2019 | $445,000 | -3.5% | 32,686 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $461,000 | -84.0% | 32,686 | -79.1% | 0.00% | -66.7% |
| Q1 2019 | $2,876,000 | +245.7% | 156,285 | +391.0% | 0.00% | +200.0% |
| Q4 2018 | $832,000 | +8.3% | 31,831 | -4.9% | 0.00% | 0.0% |
| Q3 2018 | $768,000 | +4.9% | 33,462 | -13.0% | 0.00% | 0.0% |
| Q2 2018 | $732,000 | +30.2% | 38,473 | +15.5% | 0.00% | 0.0% |
| Q1 2018 | $562,000 | +8.3% | 33,311 | -2.6% | 0.00% | 0.0% |
| Q4 2017 | $519,000 | -14.2% | 34,198 | +1.2% | 0.00% | 0.0% |
| Q3 2017 | $605,000 | +6.5% | 33,809 | -3.1% | 0.00% | 0.0% |
| Q2 2017 | $568,000 | +40.2% | 34,882 | +20.3% | 0.00% | 0.0% |
| Q1 2017 | $405,000 | +0.5% | 29,007 | +14.8% | 0.00% | 0.0% |
| Q4 2016 | $403,000 | -6.5% | 25,270 | -2.5% | 0.00% | 0.0% |
| Q3 2016 | $431,000 | +45.6% | 25,927 | -2.0% | 0.00% | – |
| Q2 2016 | $296,000 | +29.3% | 26,454 | -7.0% | 0.00% | – |
| Q1 2016 | $229,000 | -13.6% | 28,457 | -0.1% | 0.00% | – |
| Q4 2015 | $265,000 | -16.7% | 28,472 | +1.0% | 0.00% | – |
| Q3 2015 | $318,000 | -8.9% | 28,177 | +2.4% | 0.00% | – |
| Q2 2015 | $349,000 | +40.7% | 27,525 | +3.5% | 0.00% | – |
| Q1 2015 | $248,000 | -26.4% | 26,586 | +12.9% | 0.00% | – |
| Q4 2014 | $337,000 | +45.3% | 23,547 | +5.3% | 0.00% | – |
| Q3 2014 | $232,000 | -34.3% | 22,356 | +2.4% | 0.00% | -100.0% |
| Q2 2014 | $353,000 | -14.1% | 21,834 | -13.6% | 0.00% | 0.0% |
| Q1 2014 | $411,000 | +28.4% | 25,285 | -1.9% | 0.00% | – |
| Q4 2013 | $320,000 | +30.6% | 25,765 | +15.2% | 0.00% | – |
| Q3 2013 | $245,000 | +36.1% | 22,357 | +0.5% | 0.00% | – |
| Q2 2013 | $180,000 | – | 22,255 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |